🌙 ACCP ID PRN wishes a blessed Hijri New Year to all who observe.
As the new year begins, we recognize this time of reflection, renewal, and community, and celebrate the diverse cultures and traditions of the patients, colleagues, and communities we serve.
#HijriNewYear
Posaconazole delayed-release tablets💊in patients 🏥with enteric feeding tubes: use oral suspension 🚰 or crush DR tablets?
New publication ♨️📜
1⃣Summarizes current evidence
2⃣Explores practical considerations
🔗https://academic.oup.com/jac/article-abstract/81/7/dkag201/8703966?login=false
Hot off the press!♨️ Excellent review article📜 on Staphylococcus aureus bacteremia.🦠🩸
"Navigating the Challenges in Staphylococcus aureus Bloodstream Infection: A Practical Guide to Management"
Available at 🔗https://sciencedirect.com/science/article/abs/pii/S0891552025000960?via%3Dihub
#IDXposts
#IDWeek2026 registration is open! Register at 🔗https://idweek.org/registration/
October 21-24, 2026🗓️. See you in Washington, DC! ✈️
Excellent review!👍📰
Learn about
1⃣Carbapenemase classification and characteristics
2⃣Evidence-based treatment recommendations
3⃣ Where are the carbapenemases
4⃣ Changes in global landscape 🌏
🔗https://academic.oup.com/jacamr/article/8/3/dlag099/8703957?login=false
Are you attending the AACP Annual Meeting? 🤝🧑🏫
Join your fellow ID pharmacists & colleagues for a meet and greet at the Silver Bar inside the Gaylord Texan Resort and Convention Center on July 20th, 2026 🗓️. We hope to see you there!
Excellent review📜on the diagnosis 🔬, management 💊and emerging trends in encephalitis🧠🦠
🔗https://thelancet.com/journals/lancet/article/PIIS0140-6736(26)00363-6/abstract
🔗10min⏰ podcast🎙️ summary: open.spotify.com/episode/0Dt7...
Post-hoc analysis 📊 of BALANCE trial
➡️1,037 immunocompromised patients
➡️Mostly solid tumors/chemo
➡️Higher 90-day mortality (21.8%) vs overall cohort (15.3%)
➡️No difference 7 vs 14 days of ABX in immunocompromised subgroup
www.clinicalmicrobiologyandinfection.org/article/S119...
IV vs PO GNB study
👩👨n=8,263 PO vs 901 IV 🦠Mostly E. coli; PsA 3.4% 💊PO: 47% FQs, 43% BLs (mostly CPD, no dosing)
📊Results ➡️ 90-day mortality: no difference
➡️ GNB recurrence: ⬆️ IV & ⬇️ PO, differed by PO group (Supp Tables A2 and A3)
academic.oup.com/ofid/article...
🆕💥🔴Review summarizes recent clinical trials for treatment of tuberculous meningitis
🔺Disappointing result:high dose Rifampin HARVEST
🔺The only adj Rx supported is dexamethasone(may not be universal: HIV+, ACT HIV, no survival benefit)
🔺Several ongoing RCTs #idsky
www.tandfonline.com/doi/full/10....
ACCP ID PRN
AbstractBackground. Step-down oral antibiotic therapy (SDO) is commonly used to treat uncomplicated gram-negative bacteremia (GNB), but real-world treatmen
Tuberculous Meningitis (TBM) is an often lethal form of tuberculosis with damage to the brain resulting from a combination of direct effects from the causative pathogen M. tuberculosis and from the...
